{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T17:01:05Z","timestamp":1774717265476,"version":"3.50.1"},"reference-count":194,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T00:00:00Z","timestamp":1722038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fundo Europeu de Desenvolvimento Regional (FEDER)","award":["IF\/00092\/2014\/CP1255\/CT0004"],"award-info":[{"award-number":["IF\/00092\/2014\/CP1255\/CT0004"]}]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecno-logia (FCT)","award":["IF\/00092\/2014\/CP1255\/CT0004"],"award-info":[{"award-number":["IF\/00092\/2014\/CP1255\/CT0004"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Advancements in psychotropic therapy for pregnant women are pivotal for addressing maternal mental health during the perinatal period. Screening for mood and anxiety symptoms during pregnancy is recommended to enable early intervention. Psychotropic medications, including antidepressants, benzodiazepines, antipsychotics, and mood stabilizers, are commonly used, but challenges remain regarding their safety and efficacy during pregnancy. Pregnancy induces significant changes in pharmacokinetics, necessitating personalized dosing strategies and careful monitoring. Real-time monitoring technologies, such as smartphone-integrated platforms and home-based monitoring, enhance accessibility and accuracy. Prospective studies and collaboration among healthcare providers are essential for evidence-based guidelines and optimal treatment strategies. Reducing stigma around mental health during pregnancy is crucial to ensure women seek help and discuss treatment options, promoting understanding and acceptance within the community.<\/jats:p>","DOI":"10.3390\/jcm13154398","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T09:50:05Z","timestamp":1722246605000},"page":"4398","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Advances in Psychotropic Treatment for Pregnant Women: Efficacy, Adverse Outcomes, and Therapeutic Monitoring"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2434-5874","authenticated-orcid":false,"given":"B\u00e1rbara","family":"Costa","sequence":"first","affiliation":[{"name":"PerMed Research Group, Center for Health Technology and Services Research (CINTESIS), Rua Doutor Pl\u00e1cido da Costa, 4200-450 Porto, Portugal"},{"name":"CINTESIS@RISE, Faculty of Medicine, University of Porto, Alameda Professor Hern\u00e2ni Monteiro, 4200-319 Porto, Portugal"},{"name":"Department of Community Medicine, Health Information and Decision (MEDCIDS), Faculty of Medicine, University of Porto, Alameda Professor Hern\u00e2ni Monteiro, 4200-319 Porto, Portugal"},{"name":"Centre for Parasite Biology and Immunology, Department of Infectious Diseases, National Health Institute Dr. Ricardo Jorge, Rua Alexandre Herculano 321, 4000-055 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1283-1042","authenticated-orcid":false,"given":"Nuno","family":"Vale","sequence":"additional","affiliation":[{"name":"PerMed Research Group, Center for Health Technology and Services Research (CINTESIS), Rua Doutor Pl\u00e1cido da Costa, 4200-450 Porto, Portugal"},{"name":"CINTESIS@RISE, Faculty of Medicine, University of Porto, Alameda Professor Hern\u00e2ni Monteiro, 4200-319 Porto, Portugal"},{"name":"Department of Community Medicine, Health Information and Decision (MEDCIDS), Faculty of Medicine, University of Porto, Alameda Professor Hern\u00e2ni Monteiro, 4200-319 Porto, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2024,7,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1521\/psyc.2013.76.2.150","article-title":"Hospitalization-Based Treatment for Postpartum Depressed Mothers and Their Babies: Rationale, Principles, and Preliminary Follow-Up Data","volume":"76","author":"Vliegen","year":"2013","journal-title":"Psychiatry Interpers. Biol. Process."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3122\/jabfm.2011.03.100201","article-title":"Maternal Depressive Symptomatology: 16-Month Follow-up of Infant and Maternal Health-Related Quality of Life","volume":"24","author":"Darcy","year":"2011","journal-title":"J. Am. Board Fam. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00737-013-0370-y","article-title":"A Prospective Study of Thoughts of Self-Harm and Suicidal Ideation during the Postpartum Period in Women with Mood Disorders","volume":"16","author":"Pope","year":"2013","journal-title":"Arch. Womens Ment. Health"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13690-022-00792-8","article-title":"Effect of Perinatal Depression on Birth and Infant Health Outcomes: A Systematic Review and Meta-Analysis of Observational Studies from Africa","volume":"80","author":"Dadi","year":"2022","journal-title":"Arch. Public Health"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/GRF.0000000000000368","article-title":"Predictors of Postpartum Depression: A Comprehensive Review of the Last Decade of Evidence","volume":"61","author":"Guintivano","year":"2018","journal-title":"Clin. Obstet. Gynecol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Dimcea, D.A.-M., Petca, R.-C., Dumitra\u0219cu, M.C., \u0218andru, F., Mehedin\u021bu, C., and Petca, A. (2024). Postpartum Depression: Etiology, Treatment, and Consequences for Maternal Care. Diagnostics, 14.","DOI":"10.3390\/diagnostics14090865"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"McKee, K., Admon, L.K., Winkelman, T.N.A., Muzik, M., Hall, S., Dalton, V.K., and Zivin, K. (2020). Perinatal Mood and Anxiety Disorders, Serious Mental Illness, and Delivery-Related Health Outcomes, United States, 2006\u20132015. BMC Womens Health, 20.","DOI":"10.1186\/s12905-020-00996-6"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e2343711","DOI":"10.1001\/jamanetworkopen.2023.43711","article-title":"Prevalence of Perinatal Anxiety and Related Disorders in Low- and Middle-Income Countries","volume":"6","author":"Gordon","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/s10995-022-03425-2","article-title":"Prevalence and Predictors of Symptoms of Perinatal Mood and Anxiety Disorders among a Sample of Urban Black Women in the South","volume":"26","author":"Hernandez","year":"2022","journal-title":"Matern. Child Health J."},{"key":"ref_10","first-page":"e54245","article-title":"In the Shadows of Motherhood: A Comprehensive Review of Postpartum Depression Screening and Intervention Practices","volume":"16","author":"Gupta","year":"2024","journal-title":"Cureus"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Horakova, A., Nemcova, H., Hrdlickova, K., Kalli, S., Davletova, A., Duarte, M.F.R.S., Molodina, D., Riekki, T., and Sebela, A. (2024). State of Perinatal Mental Health Care in the WHO Region of Europe: A Scoping Review. Front. Psychiatry, 15.","DOI":"10.3389\/fpsyt.2024.1350036"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"S\u016bd\u017ei\u016bt\u0117, K., Murauskien\u0117, G., Jarien\u0117, K., Jaras, A., Minkauskien\u0117, M., Adomaitien\u0117, V., and Nedzelskien\u0117, I. (2020). Pre-Existing Mental Health Disorders Affect Pregnancy and Neonatal Outcomes: A Retrospective Cohort Study. BMC Pregnancy Childbirth, 20.","DOI":"10.1186\/s12884-020-03094-5"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e075462","DOI":"10.1136\/bmj-2023-075462","article-title":"Perinatal Depression and Risk of Mortality: Nationwide, Register Based Study in Sweden","volume":"384","author":"Hagatulah","year":"2024","journal-title":"BMJ"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Wohrer, F., Ngo, H., DiDomenico, J., Ma, X., Roberts, M.H., and Bakhireva, L.N. (2024). Potentially Modifiable Risk and Protective Factors Affecting Mental and Emotional Wellness in Pregnancy. Front. Hum. Neurosci., 18.","DOI":"10.3389\/fnhum.2024.1323297"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jpsychires.2018.06.019","article-title":"Predictors of Severe Relapse in Pregnant Women with Psychotic or Bipolar Disorders","volume":"104","author":"Taylor","year":"2018","journal-title":"J. Psychiatr. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1017\/S0033291715001385","article-title":"Pre-Eclampsia and First-Onset Postpartum Psychiatric Episodes: A Danish Population-Based Cohort Study","volume":"45","author":"Bergink","year":"2015","journal-title":"Psychol. Med."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Mohamed, M.A., Elhelbawy, A., Khalid, M., AbdAllatif, L.A., and Lialy, H.E. (2023). Effects of Bipolar Disorder on Maternal and Fetal Health during Pregnancy: A Systematic Review. BMC Pregnancy Childbirth, 23.","DOI":"10.1186\/s12884-023-05924-8"},{"key":"ref_18","first-page":"242","article-title":"Risks of Untreated Depression in Pregnancy","volume":"60","author":"Chan","year":"2014","journal-title":"Can. Fam. Physician"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Boisvert, C., Talarico, R., Gandhi, J., Kaluzienski, M., Dingwall-Harvey, A.L., White, R.R., Sampsel, K., Wen, S.W., Walker, M., and Muldoon, K.A. (2023). Screening for Postpartum Depression and Risk of Suicidality with Obstetrical Patients: A Cross-Sectional Survey. BMC Pregnancy Childbirth, 23.","DOI":"10.1186\/s12884-023-05903-z"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1001\/jamapsychiatry.2016.0934","article-title":"Neonatal Outcomes in Women with Untreated Antenatal Depression Compared with Women Without Depression","volume":"73","author":"Jarde","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1001\/archgenpsychiatry.2010.111","article-title":"A Meta-Analysis of Depression During Pregnancy and the Risk of Preterm Birth, Low Birth Weight, and Intrauterine Growth Restriction","volume":"67","author":"Grote","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_22","first-page":"e30656","article-title":"Maternal Mental Health during Pregnancy: A Critical Review","volume":"14","author":"Chauhan","year":"2022","journal-title":"Cureus"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1177\/0269881117699361","article-title":"British Association for Psychopharmacology Consensus Guidance on the Use of Psychotropic Medication Preconception, in Pregnancy and Postpartum 2017","volume":"31","author":"Baldwin","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/anae.15424","article-title":"Mental Disorder in Pregnancy and the Early Postpartum","volume":"76","author":"Cantwell","year":"2021","journal-title":"Anaesthesia"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Massoudi, P., Str\u00f6mwall, L.A., \u00c5hlen, J., K\u00e4rrman Fredriksson, M., Dencker, A., and Andersson, E. (2023). Women\u2019s Experiences of Psychological Treatment and Psychosocial Interventions for Postpartum Depression: A Qualitative Systematic Review and Meta-Synthesis. BMC Womens Health, 23.","DOI":"10.1186\/s12905-023-02772-8"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Kittel-Schneider, S., Felice, E., Buhagiar, R., Lambregtse-van den Berg, M., Wilson, C.A., Banjac Baljak, V., Vujovic, K.S., Medic, B., Opankovic, A., and Fonseca, A. (2022). Treatment of Peripartum Depression with Antidepressants and Other Psychotropic Medications: A Synthesis of Clinical Practice Guidelines in Europe. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19041973"},{"key":"ref_27","first-page":"629","article-title":"Benefits and Risks of Psychiatric Medications during Pregnancy","volume":"66","author":"Ward","year":"2002","journal-title":"Am. Fam. Physician"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41398-023-02514-2","article-title":"Understanding the Mechanism of Action and Clinical Effects of Neuroactive Steroids and GABAergic Compounds in Major Depressive Disorder","volume":"13","author":"Cutler","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Jaro\u0144czyk, M., and Walory, J. (2022). Novel Molecular Targets of Antidepressants. Molecules, 27.","DOI":"10.3390\/molecules27020533"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/0269881113482532","article-title":"Amphetamine, Past and Present\u2014A Pharmacological and Clinical Perspective","volume":"27","author":"Heal","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Himmerich, H., and Hamilton, A. (2022). Mood Stabilizers: Side Effects, Contraindications, and Interactions. NeuroPsychopharmacotherapy, Springer International Publishing.","DOI":"10.1007\/978-3-030-62059-2_40"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Vinkers, C.H., Kupka, R.W., Penninx, B.W., Ruh\u00e9, H.G., van Gaalen, J.M., van Haaren, P.C.F., Schellekens, A.F.A., Jauhar, S., Ramos-Quiroga, J.A., and Vieta, E. (2024). Discontinuation of Psychotropic Medication: A Synthesis of Evidence across Medication Classes. Mol. Psychiatry.","DOI":"10.1038\/s41380-024-02445-4"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Poweleit, E.A., Cinibulk, M.A., Novotny, S.A., Wagner-Schuman, M., Ramsey, L.B., and Strawn, J.R. (2022). Selective Serotonin Reuptake Inhibitor Pharmacokinetics during Pregnancy: Clinical and Research Implications. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.833217"},{"key":"ref_34","first-page":"214","article-title":"Benzodiazepine Pharmacology and Central Nervous System-Mediated Effects","volume":"13","author":"Griffin","year":"2013","journal-title":"Ochsner J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/neurolint14010005","article-title":"Antipsychotic Use in Pregnancy: Patient Mental Health Challenges, Teratogenicity, Pregnancy Complications, and Postnatal Risks","volume":"14","author":"Edinoff","year":"2022","journal-title":"Neurol. Int."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"308","DOI":"10.4103\/0019-5545.161498","article-title":"Mood Stabilizers in Pregnancy and Lactation","volume":"57","author":"Grover","year":"2015","journal-title":"Indian J. Psychiatry"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2147\/NDT.S36394","article-title":"The Use of Psychotropic Medication during Pregnancy: How about the Newborn?","volume":"9","author":"Kieviet","year":"2013","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archgenpsychiatry.2009.175","article-title":"National Trends in Psychotropic Medication Polypharmacy in Office-Based Psychiatry","volume":"67","author":"Mojtabai","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fpsyt.2020.00035","article-title":"National Prescription Patterns of Antidepressants in the Treatment of Adults with Major Depression in the US Between 1996 and 2015: A Population Representative Survey Based Analysis","volume":"11","author":"Luo","year":"2020","journal-title":"Front. Psychiatry"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"484","DOI":"10.4103\/0253-7613.165186","article-title":"Psychopharmacoteratophobia: Excessive Fear of Malformation Associated with Prescribing Psychotropic Drugs during Pregnancy: An Indian Perspective","volume":"47","author":"Ram","year":"2015","journal-title":"Indian. J. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1016\/j.wombi.2018.12.003","article-title":"An Analysis of Online Pregnancy Message Boards: Mother-to-Mother Advice on Medication Use","volume":"33","author":"Denton","year":"2020","journal-title":"Women Birth"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e20958","DOI":"10.1016\/j.heliyon.2023.e20958","article-title":"Psychiatric Illness and Pregnancy: A Literature Review","volume":"9","author":"Abdelhafez","year":"2023","journal-title":"Heliyon"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1176\/appi.focus.20190007","article-title":"Psychopharmacological Decision Making in Bipolar Disorder During Pregnancy and Lactation: A Case-by-Case Approach to Using Current Evidence","volume":"17","author":"Albertini","year":"2019","journal-title":"Focus"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"204209862095891","DOI":"10.1177\/2042098620958910","article-title":"The Art and Science of Drug Titration","volume":"11","author":"Caffrey","year":"2020","journal-title":"Ther. Adv. Drug Saf."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Jerjes, W., Ramsay, D., Stevenson, H., and Lalji, K. (2024). Mental Health Polypharmacy in \u201cNon-Coded\u201d Primary Care Patients: The Effect of Deprescribing. J. Clin. Med., 13.","DOI":"10.3390\/jcm13040958"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41573-023-00670-0","article-title":"Overcoming Barriers to Patient Adherence: The Case for Developing Innovative Drug Delivery Systems","volume":"22","author":"Baryakova","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/bcp.14914","article-title":"Ethical Issues in Therapeutic Use and Research in Pregnant and Breastfeeding Women","volume":"88","author":"Weld","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hup.2451","article-title":"Serotonin Reuptake Inhibitors and Breastfeeding: A Systematic Review","volume":"30","author":"Orsolini","year":"2015","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s40262-015-0298-7","article-title":"Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and Children","volume":"54","author":"Rodieux","year":"2015","journal-title":"Clin. Pharmacokinet."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Arbitman, L., Chen, S., Kim, B., Lee, M., Zou, P., Doughty, B., Li, Y., and Zhang, T. (2024). Assessment of Infant Exposure to Antidepressants through Breastfeeding: A Literature Review of Currently Available Approaches. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16070847"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Schoretsanitis, G., Westin, A.A., Stingl, J.C., Deligiannidis, K.M., Paulzen, M., and Spigset, O. (2021). Antidepressant Transfer into Amniotic Fluid, Umbilical Cord Blood & Breast Milk: A Systematic Review & Combined Analysis. Prog. Neuropsychopharmacol. Biol. Psychiatry, 107.","DOI":"10.1016\/j.pnpbp.2020.110228"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/GRF.0b013e3181b52bd6","article-title":"Antidepressant Medication Use during Breastfeeding","volume":"52","author":"Wisner","year":"2009","journal-title":"Clin. Obstet. Gynecol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1039\/c8tx00102b","article-title":"Maternal SSRIs Experience and Risk of ASD in Offspring: A Review","volume":"7","author":"Fatima","year":"2018","journal-title":"Toxicol. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/bcp.13194","article-title":"SSRI and SNRI Use during Pregnancy and the Risk of Persistent Pulmonary Hypertension of the Newborn","volume":"83","author":"Sheehy","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/2008-2231-20-75","article-title":"Increasing the Risk of Spontaneous Abortion and Major Malformations in Newborns Following Use of Serotonin Reuptake Inhibitors during Pregnancy: A Systematic Review and Updated Meta-Analysis","volume":"20","author":"Nikfar","year":"2012","journal-title":"DARU J. Pharm. Sci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1097\/MJT.0000000000000909","article-title":"A New Safety Scoring System for the Use of Psychotropic Drugs During Lactation","volume":"28","author":"Uguz","year":"2021","journal-title":"Am. J. Ther."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1517\/14740338.2014.869582","article-title":"Tricyclic Antidepressants in Pregnancy and Puerperium","volume":"13","author":"Gentile","year":"2014","journal-title":"Expert. Opin. Drug Saf."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1089\/jwh.2019.7781","article-title":"Psychotropic Treatment during Pregnancy: Research Synthesis and Clinical Care Principles","volume":"29","author":"Betcher","year":"2020","journal-title":"J. Womens Health"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Burke, M., Fillion, M., Mejia, J., Ervin, F., and Palmour, R. (2018). Perinatal MAO Inhibition Produces Long-Lasting Impairment of Serotonin Function in Offspring. Brain Sci., 8.","DOI":"10.3390\/brainsci8060106"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Edinoff, A.N., Odisho, A.S., Lewis, K., Kaskas, A., Hunt, G., Cornett, E.M., Kaye, A.D., Kaye, A., Morgan, J., and Barrilleaux, P.S. (2021). Brexanolone, a GABAA Modulator, in the Treatment of Postpartum Depression in Adults: A Comprehensive Review. Front. Psychiatry, 12.","DOI":"10.3389\/fpsyt.2021.699740"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1176\/appi.ajp-rj.2019.150201","article-title":"Brexanolone: A Novel Therapeutic in the Treatment of Postpartum Depression","volume":"15","author":"Diao","year":"2019","journal-title":"Am. J. Psychiatry Resid. J."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/phar.2331","article-title":"Brexanolone for Postpartum Depression: Clinical Evidence and Practical Considerations","volume":"39","author":"Leader","year":"2019","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"170435","DOI":"10.1155\/2015\/170435","article-title":"Plasticity of GABAA Receptors during Pregnancy and Postpartum Period: From Gene to Function","volume":"2015","author":"Licheri","year":"2015","journal-title":"Neural Plast."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Pinna, G. (2020). Allopregnanolone, the Neuromodulator Turned Therapeutic Agent: Thank You, Next?. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.00236"},{"key":"ref_65","unstructured":"FDA (2024, July 16). Approves First Treatment for Post-Partum Depression, Available online: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-treatment-post-partum-depression."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s00213-023-06427-2","article-title":"Preclinical and Clinical Pharmacology of Brexanolone (Allopregnanolone) for Postpartum Depression: A Landmark Journey from Concept to Clinic in Neurosteroid Replacement Therapy","volume":"240","author":"Reddy","year":"2023","journal-title":"Psychopharmacology"},{"key":"ref_67","first-page":"115","article-title":"Brexanolone to Treat Postpartum Depression in Adult Women","volume":"51","author":"Cornett","year":"2021","journal-title":"Psychopharmacol. Bull."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00737-023-01394-1","article-title":"Safety of Electroconvulsive Therapy (ECT) in Pregnancy: A Systematic Review of Case Reports and Case Series","volume":"27","author":"Cipolla","year":"2024","journal-title":"Arch. Womens Ment. Health"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/OGX.0000000000000763","article-title":"Electroconvulsive Therapy in Pregnancy: Safety, Best Practices, and Barriers to Care","volume":"75","author":"Rose","year":"2020","journal-title":"Obstet. Gynecol. Surv."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.euroneuro.2018.11.1103","article-title":"Psychopharmacological Prescribing Practices in Pregnancy for Women with Severe Mental Illness: A Multicentre Study","volume":"29","author":"Galbally","year":"2019","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40345-018-0135-7","article-title":"Lithium during Pregnancy and after Delivery: A Review","volume":"6","author":"Poels","year":"2018","journal-title":"Int. J. Bipolar Disord."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1176\/appi.ajp.157.2.179","article-title":"Risk of Recurrence of Bipolar Disorder in Pregnant and Nonpregnant Women after Discontinuing Lithium Maintenance","volume":"157","author":"Viguera","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1176\/appi.ajp.2019.19030228","article-title":"Lithium Exposure During Pregnancy and the Postpartum Period: A Systematic Review and Meta-Analysis of Safety and Efficacy Outcomes","volume":"177","author":"Fornaro","year":"2020","journal-title":"Am. J. Psychiatry"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1056\/NEJMoa1612222","article-title":"Lithium Use in Pregnancy and the Risk of Cardiac Malformations","volume":"376","author":"Patorno","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Hastie, R., Tong, S., Hiscock, R., Lindquist, A., Lindstr\u00f6m, L., Wikstr\u00f6m, A.-K., and Sundstr\u00f6m-Poromaa, I. (2021). Maternal Lithium Use and the Risk of Adverse Pregnancy and Neonatal Outcomes: A Swedish Population-Based Cohort Study. BMC Med., 19.","DOI":"10.1186\/s12916-021-02170-7"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e200289","DOI":"10.1212\/CPJ.0000000000200289","article-title":"Specific Birth Defects Following Antiseizure Medications Used by Pregnant Women with Epilepsy","volume":"14","author":"Wiggs","year":"2024","journal-title":"Neurol. Clin. Pract."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1212\/01.wnl.0000304343.45104.d6","article-title":"Increased Frequency of Isolated Cleft Palate in Infants Exposed to Lamotrigine during Pregnancy","volume":"70","author":"Holmes","year":"2008","journal-title":"Neurology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/bdr2.1079","article-title":"Antidepressants, Antipsychotics, and Mood Stabilizers in Pregnancy: What Do We Know and How Should We Treat Pregnant Women with Depression","volume":"109","author":"Ornoy","year":"2017","journal-title":"Birth Defects Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"105610","DOI":"10.1016\/j.phrs.2021.105610","article-title":"Estrogen Profile- and Pharmacogenetics-Based Lamotrigine Dosing Regimen Optimization: Recommendations for Pregnant Women with Epilepsy","volume":"169","author":"Wang","year":"2021","journal-title":"Pharmacol. Res."},{"key":"ref_80","first-page":"163","article-title":"Is Carbamazepine Safe to Take during Pregnancy?","volume":"58","author":"Matlow","year":"2012","journal-title":"Can. Fam. Physician"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Sch\u00e4fer, M., and Brandl, E.J. (2022). Mood Stabilizers: Valproate. NeuroPsychopharmacotherapy, Springer International Publishing.","DOI":"10.1007\/978-3-030-62059-2_49"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"19","DOI":"10.9758\/cpn.2017.15.1.19","article-title":"Teratogenicity of Antiepileptic Drugs","volume":"15","author":"Rosti","year":"2017","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Macfarlane, A., and Greenhalgh, T. (2018). Sodium Valproate in Pregnancy: What Are the Risks and Should We Use a Shared Decision-Making Approach?. BMC Pregnancy Childbirth, 18.","DOI":"10.1186\/s12884-018-1842-x"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"935","DOI":"10.2174\/1570159X21666230224102318","article-title":"Pharmacological Strategies for Bipolar Disorders in Acute Phases and Chronic Management with a Special Focus on Lithium, Valproic Acid, and Atypical Antipsychotics","volume":"21","author":"Carli","year":"2023","journal-title":"Curr. Neuropharmacol."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Galappatthy, P., Liyanage, C.K., Lucas, M.N., Jayasekara, D.T.L.M., Abhayaratna, S.A., Weeraratne, C., De Abrew, K., Gunaratne, P.S., Gamage, R., and Wijeyaratne, C.N. (2018). Obstetric Outcomes and Effects on Babies Born to Women Treated for Epilepsy during Pregnancy in a Resource Limited Setting: A Comparative Cohort Study. BMC Pregnancy Childbirth, 18.","DOI":"10.1186\/s12884-018-1857-3"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e2412680","DOI":"10.1001\/jamanetworkopen.2024.12680","article-title":"Prenatal Exposure to Valproic Acid across Various Indications for Use","volume":"7","author":"Smolinski","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/09603271241236346","article-title":"Epidemiology Studies on Effects of Lithium Salts in Pregnancy Are Confounded by the Inability to Control for Other Potentially Teratogenic Factors","volume":"43","author":"Smith","year":"2024","journal-title":"Hum. Exp. Toxicol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1176\/appi.ajp.2014.12111402","article-title":"Pregnancy Outcome Following in Utero Exposure to Lithium: A Prospective, Comparative, Observational Study","volume":"171","author":"Shechtman","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s40263-022-00908-2","article-title":"Antipsychotic Use During Pregnancy and Risk for Gestational Diabetes: A National Register-Based Cohort Study in Sweden","volume":"36","author":"Heinonen","year":"2022","journal-title":"CNS Drugs"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Stamou, G., Garc\u00eda-Palacios, A., and Botella, C. (2018). Cognitive-Behavioural Therapy and Interpersonal Psychotherapy for the Treatment of Post-Natal Depression: A Narrative Review. BMC Psychol., 6.","DOI":"10.1186\/s40359-018-0240-5"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40501-019-0165-5","article-title":"Use of Antipsychotic Drugs during Pregnancy","volume":"6","author":"Betcher","year":"2019","journal-title":"Curr. Treat. Options Psychiatry"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.schres.2020.03.048","article-title":"Antipsychotic Drug Use in Pregnancy: A Multinational Study from Ten Countries","volume":"220","author":"Reutfors","year":"2020","journal-title":"Schizophr. Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/bcpt.12372","article-title":"Pregnancy Exposure to Olanzapine, Quetiapine, Risperidone, Aripiprazole and Risk of Congenital Malformations. A Systematic Review","volume":"116","author":"Ennis","year":"2015","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4103\/ipj.ipj_269_21","article-title":"Adding Pre-Emptive Anticholinergics to Antipsychotics: Is It Justified?","volume":"31","author":"Chatterjee","year":"2022","journal-title":"Ind. Psychiatry J."},{"key":"ref_95","first-page":"e51510","article-title":"Navigating the Complexity of a Bipolar Pregnant Patient with Multiple Comorbidities","volume":"16","author":"Traugott","year":"2024","journal-title":"Cureus"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e003062","DOI":"10.1136\/bmjopen-2013-003062","article-title":"Pregnancy Outcomes Following Maternal Exposure to Second-Generation Antipsychotics given with Other Psychotropic Drugs: A Cohort Study","volume":"3","author":"Sadowski","year":"2013","journal-title":"BMJ Open"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Subramanian, A., Azcoaga-Lorenzo, A., Anand, A., Phillips, K., Lee, S.I., Cockburn, N., Fagbamigbe, A.F., Damase-Michel, C., Yau, C., and McCowan, C. (2023). Polypharmacy during Pregnancy and Associated Risk Factors: A Retrospective Analysis of 577 Medication Exposures among 1.5 Million Pregnancies in the UK, 2000-2019. BMC Med., 21.","DOI":"10.1186\/s12916-022-02722-5"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.rbmo.2015.11.016","article-title":"Investigation of Possible Teratogenic Effects in the Offspring of Mice Exposed to Methylphenidate during Pregnancy","volume":"32","author":"Costa","year":"2016","journal-title":"Reprod. Biomed. Online"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/1087054718759753","article-title":"ADHD Medication Use During Pregnancy and Risk for Selected Birth Defects: National Birth Defects Prevention Study, 1998\u20132011","volume":"24","author":"Anderson","year":"2020","journal-title":"J. Atten. Disord."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s40263-020-00728-2","article-title":"Associations of Prescribed ADHD Medication in Pregnancy with Pregnancy-Related and Offspring Outcomes: A Systematic Review","volume":"34","author":"Li","year":"2020","journal-title":"CNS Drugs"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/bmj.317.7162.839","article-title":"Benzodiazepine Use in Pregnancy and Major Malformations or Oral Cleft: Meta-Analysis of Cohort and Case-Control Studies","volume":"317","author":"Dolovich","year":"1998","journal-title":"BMJ"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4103\/JCRP.JCRP_10_19","article-title":"Future of 5-Fluorouracil in Cancer Therapeutics, Current Pharmacokinetics Issues and a Way Forward","volume":"6","author":"Iqbal","year":"2019","journal-title":"J. Cancer Res. Pract."},{"key":"ref_103","unstructured":"Ghiasi, N., Bhansali, R.K., and Marwaha, R. (2023). Lorazepam. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ogc.2020.11.006","article-title":"Psychiatric Medication Use in Pregnancy and Breastfeeding","volume":"48","author":"Payne","year":"2021","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"key":"ref_105","unstructured":"Bouchette, D., Akhondi, H., and Quick, J. (2022). Zolpidem.[Updated 2022 Oct 1]. StatPearls [Internet, StatPearls Publishing."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/wps.20777","article-title":"Prenatal Mental Health and the Effects of Stress on the Foetus and the Child. Should Psychiatrists Look beyond Mental Disorders?","volume":"19","author":"Glover","year":"2020","journal-title":"World Psychiatry"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/wps.20769","article-title":"Perinatal Mental Health: A Review of Progress and Challenges","volume":"19","author":"Howard","year":"2020","journal-title":"World Psychiatry"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/GRF.0000000000000724","article-title":"Adverse Pregnancy Outcomes and Postpartum Care as a Pathway to Future Health","volume":"65","author":"Johnson","year":"2022","journal-title":"Clin. Obstet. Gynecol."},{"key":"ref_109","first-page":"100849","article-title":"Prenatal Exposure to Antiseizure Medications and Fetal Growth: A Population-Based Cohort Study from the Nordic Countries","volume":"38","author":"Christensen","year":"2024","journal-title":"Lancet Reg. Health-Eur."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"8986014","DOI":"10.1155\/2020\/8986014","article-title":"Relapse and Clinical Characteristics of Patients with Bipolar Disorders in Central Ethiopia: A Cross-Sectional Study","volume":"2020","author":"Belete","year":"2020","journal-title":"Psychiatry J."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Chow, R.T.S., Whiting, D., Favril, L., Ostinelli, E., Cipriani, A., and Fazel, S. (2023). An Umbrella Review of Adverse Effects Associated with Antipsychotic Medications: The Need for Complementary Study Designs. Neurosci. Biobehav. Rev., 155.","DOI":"10.1016\/j.neubiorev.2023.105454"},{"key":"ref_112","first-page":"e47044","article-title":"Effects of Prenatal Stress on Behavior, Cognition, and Psychopathology: A Comprehensive Review","volume":"15","author":"Jagtap","year":"2023","journal-title":"Cureus"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1176\/appi.ajp.2007.06111886","article-title":"Atypical Antipsychotic Administration during Late Pregnancy: Placental Passage and Obstetrical Outcomes","volume":"164","author":"Newport","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"221","DOI":"10.48095\/cccg2023221","article-title":"Use of Antipsychotics during Pregnancy and Their Impact on Congenital Malformations and Early Neonatal Adaptation","volume":"88","year":"2023","journal-title":"Ceska Gynekol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"5645","DOI":"10.1017\/S0033291722002859","article-title":"Neonatal Withdrawal Syndrome Following in Utero Exposure to Antidepressants: A Disproportionality Analysis of VigiBase, the WHO Spontaneous Reporting Database","volume":"53","author":"Gastaldon","year":"2023","journal-title":"Psychol. Med."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.3928\/19382359-20191211-01","article-title":"Neonatal Abstinence Syndrome","volume":"49","author":"Khan","year":"2020","journal-title":"Pediatr. Ann."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/archdischild-2023-326049","article-title":"Maternal Treatment with Selective Serotonin Reuptake Inhibitors during Pregnancy and Delayed Neonatal Adaptation: A Population-Based Cohort Study","volume":"109","author":"Cornet","year":"2024","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s11920-022-01372-x","article-title":"Selective Serotonin Reuptake Inhibitors (SSRIs) in Pregnancy: An Updated Review on Risks to Mother, Fetus, and Child","volume":"24","author":"Lebin","year":"2022","journal-title":"Curr. Psychiatry Rep."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1176\/appi.ajp.2012.11121873","article-title":"Does Fetal Exposure to SSRIs or Maternal Depression Impact Infant Growth?","volume":"170","author":"Wisner","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Bluett-Duncan, M., Kishore, M.T., Patil, D.M., Satyanarayana, V.A., and Sharp, H. (2021). A Systematic Review of the Association between Perinatal Depression and Cognitive Development in Infancy in Low and Middle-Income Countries. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0253790"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"105075","DOI":"10.1016\/j.earlhumdev.2020.105075","article-title":"Intra-Uterine Exposure to Selective Serotonin Reuptake Inhibitors (SSRIs), Maternal Psychopathology, and Neurodevelopment at Age 2.5years\u2014Results from the Prospective Cohort SMOK Study","volume":"147","author":"Bos","year":"2020","journal-title":"Early Hum. Dev."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1111\/1471-0528.13582","article-title":"Motor Development in Children Prenatally Exposed to Selective Serotonin Reuptake Inhibitors: A Large Population-based Pregnancy Cohort Study","volume":"123","author":"Handal","year":"2016","journal-title":"BJOG"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"102531","DOI":"10.1016\/j.eclinm.2024.102531","article-title":"Antipsychotic Use during Pregnancy and Risk of Specific Neurodevelopmental Disorders and Learning Difficulties in Children: A Multinational Cohort Study","volume":"70","author":"Bruno","year":"2024","journal-title":"eClinicalMedicine"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.genhosppsych.2009.04.003","article-title":"The Management of Depression during Pregnancy: A Report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists","volume":"31","author":"Yonkers","year":"2009","journal-title":"Gen. Hosp. Psychiatry"},{"key":"ref_125","unstructured":"Mughal, S., Azhar, Y., and Siddiqui, W. (2018). Postpartum depression. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"9350","DOI":"10.12998\/wjcc.v9.i31.9350","article-title":"Major Depressive Disorder: Validated Treatments and Future Challenges","volume":"9","author":"Karrouri","year":"2021","journal-title":"World J. Clin. Cases"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Chang, Q., Ma, X.-Y., Xu, X.-R., Su, H., Wu, Q.-J., and Zhao, Y.-H. (2020). Antidepressant Use in Depressed Women During Pregnancy and the Risk of Preterm Birth: A Systematic Review and Meta-Analysis of 23 Cohort Studies. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.00659"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s44294-024-00008-0","article-title":"Antidepressant Use during Pregnancy and the Risk of Preterm Birth\u2014A Cohort Study","volume":"2","author":"Amit","year":"2024","journal-title":"npj Women\u2019s Health"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/17425255.2020.1750598","article-title":"The Impact of Pregnancy on the Pharmacokinetics of Antidepressants: A Systematic Critical Review and Meta-Analysis","volume":"16","author":"Schoretsanitis","year":"2020","journal-title":"Expert. Opin. Drug Metab. Toxicol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/ADM.0000000000000370","article-title":"Optimizing Pregnancy Treatment Interventions for Moms (OPTI-Mom): A Pilot Study","volume":"12","author":"Cochran","year":"2018","journal-title":"J. Addict. Med."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Charron, E., White, A., Carlston, K., Abdullah, W., Baylis, J.D., Pierce, S., Businelle, M.S., Gordon, A.J., Krans, E.E., and Smid, M.C. (2023). Prospective Acceptability of Digital Phenotyping among Pregnant and Parenting People with Opioid Use Disorder: A Multisite Qualitative Study. Front. Psychiatry, 14.","DOI":"10.3389\/fpsyt.2023.1137071"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Pariente, G., Leibson, T., Carls, A., Adams-Webber, T., Ito, S., and Koren, G. (2016). Pregnancy-Associated Changes in Pharmacokinetics: A Systematic Review. PLoS Med., 13.","DOI":"10.1371\/journal.pmed.1002160"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/j.semperi.2015.08.003","article-title":"Pharmacokinetics of Drugs in Pregnancy","volume":"39","author":"Feghali","year":"2015","journal-title":"Semin. Perinatol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/cpt.770","article-title":"Treatment with Antipsychotics in Pregnancy: Changes in Drug Disposition","volume":"103","author":"Westin","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"e015738","DOI":"10.1136\/bmjopen-2016-015738","article-title":"Changes in Drug Disposition of Lithium during Pregnancy: A Retrospective Observational Study of Patient Data from Two Routine Therapeutic Drug Monitoring Services in Norway","volume":"7","author":"Westin","year":"2017","journal-title":"BMJ Open"},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Gerlach, A.T., and Saliba, L. (2016). Practical Pharmacokinetics and Pharmacodynamics. Principles of Adult Surgical Critical Care, Springer International Publishing.","DOI":"10.1007\/978-3-319-33341-0_41"},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Mittal, A., Ghai, R., Srivastava, A., Ghosh, D.P., and Nagarajan, K. (2023). Pharmacokinetics and Pharmacodynamics: Fundamentals and Role(s) in Drug Discovery and Development. Recent Advances in Pharmaceutical Innovation and Research, Springer Nature.","DOI":"10.1007\/978-981-99-2302-1_15"},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Tyson, R.J., Park, C.C., Powell, J.R., Patterson, J.H., Weiner, D., Watkins, P.B., and Gonzalez, D. (2020). Precision Dosing Priority Criteria: Drug, Disease, and Patient Population Variables. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.00420"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/FTD.0000000000001039","article-title":"Optimizing Therapeutic Drug Monitoring in Pregnant Women: A Critical Literature Review","volume":"45","author":"Moreira","year":"2023","journal-title":"Ther. Drug Monit."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/FTD.0b013e318261c372","article-title":"Therapeutic Drug Monitoring in Pregnancy","volume":"34","author":"Matsui","year":"2012","journal-title":"Ther. Drug Monit."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1016\/j.clinthera.2017.05.290","article-title":"Importance of TDM during Pregnancy and Breastfeeding","volume":"39","author":"Kacirova","year":"2017","journal-title":"Clin. Ther."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3904\/kjim.2009.24.1.1","article-title":"Overview of Therapeutic Drug Monitoring","volume":"24","author":"Kang","year":"2009","journal-title":"Korean J. Intern. Med."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Liang, W.S., Beaulieu-Jones, B., Smalley, S., Snyder, M., Goetz, L.H., and Schork, N.J. (2024). Emerging Therapeutic Drug Monitoring Technologies: Considerations and Opportunities in Precision Medicine. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1348112"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1093\/jac\/dkad289","article-title":"A Novel Strategy for Therapeutic Drug Monitoring: Application of Biosensors to Quantify Antimicrobials in Biological Matrices","volume":"78","author":"Wang","year":"2023","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Tovar-Lopez, F.J. (2023). Recent Progress in Micro- and Nanotechnology-Enabled Sensors for Biomedical and Environmental Challenges. Sensors, 23.","DOI":"10.3390\/s23125406"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.2174\/0929867324666170720101736","article-title":"Biosensing Technologies for Therapeutic Drug Monitoring","volume":"25","author":"Meneghello","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Sanavio, B., and Krol, S. (2015). On the Slow Diffusion of Point-of-Care Systems in Therapeutic Drug Monitoring. Front. Bioeng. Biotechnol., 3.","DOI":"10.3389\/fbioe.2015.00020"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2165\/00003088-197702060-00003","article-title":"Plasma Drug Level Monitoring in Pregnancy","volume":"2","author":"Eadie","year":"1977","journal-title":"Clin. Pharmacokinet."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Coppola, P., Butler, A., Cole, S., and Kerwash, E. (2023). Total and Free Blood and Plasma Concentration Changes in Pregnancy for Medicines Highly Bound to Plasma Proteins: Application of Physiologically Based Pharmacokinetic Modelling to Understand the Impact on Efficacy. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15102455"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpha.2020.08.001","article-title":"Towards Wearable and Implantable Continuous Drug Monitoring: A Review","volume":"11","author":"Bian","year":"2021","journal-title":"J. Pharm. Anal."},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Janghorban, M., Aradanas, I., Kazemi, S., Ngaju, P., and Pandey, R. (2022). Recent Advances, Opportunities, and Challenges in Developing Nucleic Acid Integrated Wearable Biosensors for Expanding the Capabilities of Wearable Technologies in Health Monitoring. Biosensors, 12.","DOI":"10.3390\/bios12110986"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"100257","DOI":"10.1016\/j.sintl.2023.100257","article-title":"Biosensors and Their Widespread Impact on Human Health","volume":"5","author":"Bhatia","year":"2024","journal-title":"Sens. Int."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Coppola, P., Kerwash, E., Nooney, J., Omran, A., and Cole, S. (2022). Pharmacokinetic Data in Pregnancy: A Review of Available Literature Data and Important Considerations in Collecting Clinical Data. Front. Med., 9.","DOI":"10.3389\/fmed.2022.940644"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Sharma, S., and Tharani, L. (2021). Photonics for AI and AI for Photonics: Material and Characteristics Integration. Fiber Optics\u2014Technology and Applications, IntechOpen.","DOI":"10.5772\/intechopen.97781"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"181450","DOI":"10.1109\/ACCESS.2020.3028333","article-title":"Artificial Intelligence in Pregnancy: A Scoping Review","volume":"8","author":"Oprescu","year":"2020","journal-title":"IEEE Access"},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Saylam, B., and \u0130ncel, \u00d6.D. (2023). Quantifying Digital Biomarkers for Well-Being: Stress, Anxiety, Positive and Negative Affect via Wearable Devices and Their Time-Based Predictions. Sensors, 23.","DOI":"10.20944\/preprints202310.0463.v1"},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Krizea, M., Gialelis, J., Protopsaltis, G., Mountzouris, C., and Theodorou, G. (2022). Empowering People with a User-Friendly Wearable Platform for Unobtrusive Monitoring of Vital Physiological Parameters. Sensors, 22.","DOI":"10.3390\/s22145226"},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Shajari, S., Kuruvinashetti, K., Komeili, A., and Sundararaj, U. (2023). The Emergence of AI-Based Wearable Sensors for Digital Health Technology: A Review. Sensors, 23.","DOI":"10.3390\/s23239498"},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Alim, A., and Imtiaz, M.H. (2023). Wearable Sensors for the Monitoring of Maternal Health\u2014A Systematic Review. Sensors, 23.","DOI":"10.3390\/s23052411"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"e28628","DOI":"10.2196\/28628","article-title":"Users\u2019 Perceptions Toward MHealth Technologies for Health and Well-Being Monitoring in Pregnancy Care: Qualitative Interview Study","volume":"5","author":"Li","year":"2021","journal-title":"JMIR Form. Res."},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Le Merdy, M., Szeto, K.X., Perrier, J., Bolger, M.B., and Lukacova, V. (2024). PBPK Modeling Approach to Predict the Behavior of Drugs Cleared by Metabolism in Pregnant Subjects and Fetuses. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16010096"},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Alnezary, F.S., Almutairi, M.S., Gonzales-Luna, A.J., and Thabit, A.K. (2023). The Significance of Bayesian Pharmacokinetics in Dosing for Critically Ill Patients: A Primer for Clinicians Using Vancomycin as an Example. Antibiotics, 12.","DOI":"10.3390\/antibiotics12091441"},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Marques, L., Costa, B., Pereira, M., Silva, A., Santos, J., Saldanha, L., Silva, I., Magalh\u00e3es, P., Schmidt, S., and Vale, N. (2024). Advancing Precision Medicine: A Review of Innovative In Silico Approaches for Drug Development, Clinical Pharmacology and Personalized Healthcare. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16030332"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1002\/jcph.2282","article-title":"Pharmacokinetics of Antidepressants in Pregnancy","volume":"63","author":"Yue","year":"2023","journal-title":"J. Clin. Pharmacol."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"George, B., Lumen, A., Nguyen, C., Wesley, B., Wang, J., Beitz, J., and Crentsil, V. (2020). Application of Physiologically Based Pharmacokinetic Modeling for Sertraline Dosing Recommendations in Pregnancy. NPJ Syst. Biol. Appl., 6.","DOI":"10.1038\/s41540-020-00157-3"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/jpp\/rgad106","article-title":"Precision Dosing of Venlafaxine during Pregnancy: A Pharmacokinetics Modelling Approach","volume":"76","author":"Alenezi","year":"2024","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"204512532110458","DOI":"10.1177\/20451253211045870","article-title":"Efficacy and Safety of Lamotrigine in the Treatment of Bipolar Disorder across the Lifespan: A Systematic Review","volume":"11","author":"Besag","year":"2021","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/acn3.29","article-title":"Model-based Lamotrigine Clearance Changes during Pregnancy: Clinical Implication","volume":"1","author":"Polepally","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3390\/futurepharmacol4020018","article-title":"Physiologically Based Pharmacokinetic Modelling of UGT Substrate Drugs Lamotrigine and Raltegravir during Pregnancy","volume":"4","author":"Berezowska","year":"2024","journal-title":"Future Pharmacol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/bcp.15018","article-title":"Physiologically Based Pharmacokinetic Modelling in Pregnancy: Model Reproducibility and External Validation","volume":"88","author":"Silva","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Zheng, L., Yang, H., Dallmann, A., Jiang, X., Wang, L., and Hu, W. (2022). Physiologically Based Pharmacokinetic Modeling in Pregnant Women Suggests Minor Decrease in Maternal Exposure to Olanzapine. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.793346"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/cts.13473","article-title":"Physiologically-based Pharmacokinetic Model to Investigate the Effect of Pregnancy on Risperidone and Paliperidone Pharmacokinetics: Application to a Pregnant Woman and Her Neonate","volume":"16","author":"Mahdy","year":"2023","journal-title":"Clin. Transl. Sci."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/bcp.15533","article-title":"Psychotropic Medication in Pregnancy and Lactation and Early Development of Exposed Children","volume":"89","author":"Leutritz","year":"2023","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.dmpk.2019.09.002","article-title":"Pharmacokinetic Assessment of Alprazolam-Induced Neonatal Abstinence Syndrome Using Physiologically Based Pharmacokinetic Model","volume":"34","author":"Yamamoto","year":"2019","journal-title":"Drug Metab. Pharmacokinet."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S2215-0366(23)00148-7","article-title":"Association between Maternal Benzodiazepine or Z-Hypnotic Use in Early Pregnancy and the Risk of Stillbirth, Preterm Birth, and Small for Gestational Age: A Nationwide, Population-Based Cohort Study in Taiwan","volume":"10","author":"Meng","year":"2023","journal-title":"Lancet Psychiatry"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/15357597241227656","article-title":"Caution: Benzodiazepines in Pregnancy and Risk of Adverse Perinatal Outcomes","volume":"24","year":"2024","journal-title":"Epilepsy Curr."},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Noh, Y., Lee, H., Choi, A., Kwon, J.S., Choe, S.-A., Chae, J., Kim, D.-S., and Shin, J.-Y. (2022). First-Trimester Exposure to Benzodiazepines and Risk of Congenital Malformations in Offspring: A Population-Based Cohort Study in South Korea. PLoS Med., 19.","DOI":"10.1371\/journal.pmed.1003945"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00737-023-01290-8","article-title":"Exposure to Psychotropic Drugs before and during Pregnancy: What Has Changed over the Last Two Decades?","volume":"26","author":"Robiyanto","year":"2023","journal-title":"Arch. Womens Ment. Health"},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Hanley, G.E., and Mintzes, B. (2014). Patterns of Psychotropic Medicine Use in Pregnancy in the United States from 2006 to 2011 among Women with Private Insurance. BMC Pregnancy Childbirth, 14.","DOI":"10.1186\/1471-2393-14-242"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.euroneuro.2022.01.115","article-title":"Psychotropic Drug Utilization Patterns in Pregnant Women with Bipolar Disorder: A 16-Year Population-Based Cohort Study","volume":"57","author":"Kan","year":"2022","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/pds.4789","article-title":"Use of Real-world Evidence from Healthcare Utilization Data to Evaluate Drug Safety during Pregnancy","volume":"28","author":"Huybrechts","year":"2019","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"e010130","DOI":"10.1136\/bmjopen-2015-010130","article-title":"Decisions about the Use of Psychotropic Medication during Pregnancy: A Qualitative Study","volume":"6","author":"Stevenson","year":"2016","journal-title":"BMJ Open"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.mayocpiqo.2023.02.002","article-title":"Poor Neonatal Adaptation after Antidepressant Exposure during the Third Trimester in a Geographically Defined Cohort","volume":"7","author":"Brumbaugh","year":"2023","journal-title":"Mayo Clin. Proc. Innov. Qual. Outcomes"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1701-2163(16)32135-1","article-title":"Can Venlafaxine in Breast Milk Attenuate the Norepinephrine and Serotonin Reuptake Neonatal Withdrawal Syndrome?","volume":"28","author":"Koren","year":"2006","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"ref_185","first-page":"141","article-title":"Neonatal Abstinence Syndrome: Assessment and Management","volume":"2","author":"Finnegan","year":"1975","journal-title":"Addict. Dis."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.siny.2019.01.003","article-title":"Beyond the Finnegan Scoring System: Novel Assessment and Diagnostic Techniques for the Opioid-Exposed Infant","volume":"24","author":"Schiff","year":"2019","journal-title":"Semin. Fetal Neonatal Med."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4081\/jphia.2022.2201","article-title":"Improving Inter-Rater Reliability of the Enhancing Assessment of Common Therapeutic Factors (ENACT) Measure through Training of Raters","volume":"13","author":"Mwenge","year":"2022","journal-title":"J. Public Health Afr."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0890-6238(94)90029-9","article-title":"The Effects of Benzodiazepine Use during Pregnancy and Lactation","volume":"8","author":"McElhatton","year":"1994","journal-title":"Reprod. Toxicol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1089\/bfm.2020.0259","article-title":"Benzodiazepine Concentrations in the Breast Milk and Plasma of Nursing Mothers: Estimation of Relative Infant Dose","volume":"16","author":"Nishimura","year":"2021","journal-title":"Breastfeed. Med."},{"key":"ref_190","unstructured":"George, T.T., and Tripp, J. (2023). Alprazolam. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"Parpinel, G., Rosso, G., Galante, A., Germano, C., Aragno, E., Girlando, F., Messina, A., Laudani, M.E., Rolfo, A., and Attini, R. (2022). Effect of Depressive Disorders and Their Pharmacological Treatment during Pregnancy on Maternal and Neonatal Outcome. J. Clin. Med., 11.","DOI":"10.3390\/jcm11061486"},{"key":"ref_192","doi-asserted-by":"crossref","unstructured":"Tharp, M.A., Silvola, R.M., Marks, C., Teal, E., Quinney, S.K., and Haas, D.M. (2022). Does Lack of Exposure to Individual Antidepressants at Different Points during Pregnancy Associate with Reduced Risk of Adverse Newborn Outcomes?. BMC Pregnancy Childbirth, 22.","DOI":"10.1186\/s12884-022-05287-6"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s11096-018-0672-2","article-title":"Learning the Effects of Psychotropic Drugs during Pregnancy Using Real-World Safety Data: A Paradigm Shift toward Modern Pharmacovigilance","volume":"40","author":"Lupattelli","year":"2018","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jamainternmed.2021.4571","article-title":"Association Between Prenatal Exposure to Antipsychotics and Attention-Deficit\/Hyperactivity Disorder, Autism Spectrum Disorder, Preterm Birth, and Small for Gestational Age","volume":"181","author":"Wang","year":"2021","journal-title":"JAMA Intern. Med."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/15\/4398\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:24:58Z","timestamp":1760109898000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/15\/4398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,27]]},"references-count":194,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["jcm13154398"],"URL":"https:\/\/doi.org\/10.3390\/jcm13154398","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,27]]}}}